Intel vs Qualcomm: Which AI Stock Is The Better Buy

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • Intel's sixth straight revenue beat featured 22% Data Center and AI growth, while Qualcomm's record $1.3 billion auto quarter offset a 13% handset decline.

  • Intel pours capital into manufacturing with $5 billion in quarterly capex, while Qualcomm returns cash by authorizing a $20 billion share repurchase.

  • Intel's stock has surged 263% year to date, likely already pricing in foundry success not yet visible in GAAP profits, making Qualcomm the easier valuation to underwrite.

  • Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

Intel vs Qualcomm: Which AI Stock Is The Better Buy

© 24/7 Wall St.

Intel (NASDAQ: INTC | INTC Price Prediction) and Qualcomm (NASDAQ: QCOM) both just delivered earnings that tell very different stories about how to win in AI silicon. Intel posted a sixth straight revenue beat while absorbing a $4.07 billion Mobileye charge. Qualcomm landed its fourth consecutive EPS beat with handset weakness offset by record auto.

Foundry Momentum Carries Intel. Cars Carry Qualcomm.

Intel’s Q1 FY2026 earnings report showed $13.577 billion in revenue, up 7.2% year over year, with Data Center and AI climbing 22% to $5.052 billion and Intel Foundry up 16%.

CEO Lip-Bu Tan framed the moment plainly: “The next wave of AI will bring intelligence closer to the end user, moving from foundational models to inference to agentic.” Non-GAAP gross margin expanded to 41%, a real signal that the 18A ramp is paying off.

INTC earnings explorer

Qualcomm’s quarter looked steadier and stranger. Revenue of $10.599 billion slipped 3.46% year over year. Handsets fell 13% to $6.024 billion on memory constraints and weak Chinese OEM demand.

Automotive ripped 38% higher to a record $1.326 billion, and IoT added 9%. Cristiano Amon told investors Qualcomm is now “in a period of profound industry transformation” tied to AI agents.

QCOM earnings explorer
An infographic titled 'AI Silicon Battle: Intel vs. Qualcomm' on a dark background. It shows two distinct columns comparing Intel (INTC) and Qualcomm (QCOM) strategies. Intel's section focuses on 'Rebuilding Manufacturing & Foundry Momentum' with details on CAPEX, Ireland Fab Buyback, Penang Expansion, Core Bet on U.S. Foundry and Xeon for AI Hosts, and Marquee Win with Xeon 6. Qualcomm's section focuses on 'Returning Capital & Diversification' with details on Share Repurchases, $20 Billion Repurchase Authorization, Core Bet on Snapdragon Expansion into Auto and Data Center, and Hyperscaler Custom Silicon shipping later in Calendar 2026. Below this, a 'Q1/Q2 FY2026 Performance Snapshot' table compares Intel's Q1 FY2026 figures (Revenue, Non-GAAP EPS, Data Center & AI, Intel Foundry, Non-GAAP Gross Margin, GAAP Net Loss) and Qualcomm's Q2 FY2026 figures (Revenue, Non-GAAP EPS, Automotive, IoT, Handsets, Net Income). A section for 'AI & Future Outlook' provides 'Intel's Next Test' including Q2 Guide, Watch For items, and a CEO Quote, alongside 'Qualcomm's Next Catalyst' including June 24 Investor Day, Watch For items, Chinese Handset Recovery, and a CEO Quote. Finally, 'Market Performance (YTD as of June 21, 2026)' shows Intel at +263.12% and Qualcomm at +33.55%, with Intel Forward P/E: 154 and Qualcomm Trailing P/E: 24, Yield: 1.67%.
24/7 Wall St.

One Rebuilds Manufacturing. One Buys Back Stock.

The strategic split is the whole story. Intel is pouring capital into wafers, with $4.963 billion in Q1 capex, an Ireland fab buyback, and a fresh Penang expansion.

Qualcomm is doing the opposite, returning cash aggressively. Management authorized a $20 billion repurchase and bought back $2.8 billion in shares last quarter alone.

Lens Intel Qualcomm
Core Bet U.S. foundry plus Xeon for AI hosts Snapdragon expansion into auto and data center
Marquee Win Xeon 6 selected for NVIDIA DGX Rubin NVL8 Hyperscaler custom silicon shipping in 2026
Key Vulnerability GAAP losses, capex risk if 14A demand slips Handset concentration, Apple vertical integration

Intel’s forward P/E of 154 reflects an earnings recovery the market is willing to underwrite. Qualcomm trades at a far more grounded 24 trailing P/E with a 1.67% yield. Two different risk profiles, same end market.

The Next Test Is Whether Diversification Sticks

I will be watching Intel’s Q2 guide of $13.8 billion to $14.8 billion and whether 18A yields hold as volume scales. The Google ASIC partnership and the reported Apple production tie-up could reshape the foundry narrative if either delivers signed wafer commitments.

For Qualcomm, the June 24 Investor Day is the catalyst. The key items to watch are hard data center revenue targets and any color on the Alphawave integration. The Chinese handset trough is expected to bottom in Q3 and recover in Q4, so any slip there changes the math fast.

Why I Lean Toward Qualcomm If I Had to Choose Today

Intel’s chart has been remarkable. The stock is up 263.12% year to date and 100.64% since the April earnings release. That run already prices in a lot of foundry success that has yet to show up in GAAP profit.

For me, Qualcomm’s mix of record auto growth, a real dividend, and a credible data center entry feels easier to underwrite. Intel offers turnaround torque for investors who can tolerate restructuring noise, while one more clean quarter would further validate the thesis.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SMCI Vol: 83,951,435
ON Vol: 5,844,010
ABBV Vol: 4,648,046
SWKS Vol: 2,906,448
GLW Vol: 9,068,162

Top Losing Stocks

CTRA Vol: 73,319,495
VRSN Vol: 733,407
GEN Vol: 3,048,459
MRNA Vol: 5,538,575
LULU Vol: 2,909,831